Valeant Viscoelastic Study for Cataract Surgery

Study Overview

About the Valeant Viscoelastic Study

Restivo Laser Vision sought volunteers to participate in a clinical research study evaluating a new investigational device used during cataract surgery.

During cataract surgery, OVDs are injected into the anterior chamber of the eye to maintain space, protect the delicate corneal endothelium from surgical instruments and ultrasound energy, and stabilize the eye for precise IOL implantation. The quality and performance of the OVD directly affects the safety and outcomes of the procedure.

Restivo Laser Vision takes pride in offering the latest, most innovative technologies available to our patients. Many of these technologies were developed as a result of clinical trials that help Restivo Laser Vision and the ophthalmology community make advances in the treatment of eye disease.

Eligibility

Who Was This Study For?

You may have been eligible to participate if:

• You had a clinically documented diagnosis of age-related cataracts
• You were at least 45 years old
• You were willing to undergo surgery to remove the cataract and insert an intraocular lens (IOL)
• You were willing to return for required check-ups for up to 90 days after surgery

Participation

What Did Participation Involve?

The study involved multiple visits to Restivo Laser Vision, and eligible participants could receive compensation for their participation. Enrolled participants underwent standard cataract surgery with the investigational viscoelastic (OVD) substituted for the standard commercial product, and the study evaluated:

• Corneal endothelial cell density (measured by specular microscopy before and after surgery)
• Intraocular pressure measurements at each follow-up visit
• Visual acuity and refraction outcomes
• Slit-lamp examination of the anterior segment
• Patient-reported comfort and experience
• Multiple follow-up visits at 1 day, 1 week, 1 month, and 3 months post-surgery

Study Contact

Study Coordinator